With 61.15 million shares changed hands, the volume of the stock remained heavier than its average volume of 7.5 million shares. The 52-week range on GERN shows that it touched its highest point at $3.73 and its lowest point at $1.68 during that stretch. It currently has a 1-year price target of $4.75. Beta for the stock currently stands at 0.54.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GERN was down-trending over the past week, with a drop of -10.05%, but this was down by -10.90% over a month. Three-month performance dropped to -9.18% while six-month performance fell -19.66%. The stock lost -26.85% in the past year, while it has lost -10.90% so far this year. A look at the trailing 12-month EPS for GERN yields -0.32 with Next year EPS estimates of -0.12. For the next quarter, that number is -0.10. This implies an EPS growth rate of 0.00% for this year and 63.02% for next year. EPS is expected to grow by 5.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -16.08%.
Float and Shares Shorts:
At present, 544.91 million GERN shares are outstanding with a float of 447.58 million shares on hand for trading. On Feb 29, 2024, short shares totaled 44.91 million, which was 8.22% higher than short shares on Jan 31, 2024. In addition to Dr. John A. Scarlett M.D. as the firm’s Chairman of the Board, President & CEO, Dr. Andrew J. Grethlein Ph.D. serves as its Executive VP & COO.
Institutional Ownership:
Through their ownership of 73.01% of GERN’s outstanding shares, institutional investors have majority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GERN since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
Dividends & Yield:
In terms of dividends, GERN has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and GERN currently yields $0.00. In the past year, GERN’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, GERN has a current buyback yield of $––. This was $–– for the TTM, and it was $–– for the past five years.
